ODT Staff03.08.22
VUZE Medical has bolstered its IP protection with three new patents.
U.S., European, and Chinese regulators awarded the company patents for its VUZE System, a software-only solution that overlays a graphical representation of tools seen in intra-operative 2D images onto axial and sagittal views generated from the patient’s standard pre-operative 3D scan. The U.S. Food and Drug Administration granted the System 510(k) clearance in January.
“These new patents further establish our intellectual property as one of the unique strengths of the VUZE solution,” said David Tolkowsky, VUZE Medical CEO. “We believe that our continued commitment to investing in IP will translate in the near future into further patents granted worldwide.”
Chinese Patent No. 109195527B and European Patent No. 3429475 follow previously issued U.S. Patent No. 10716631 in describing the core workflow of the VUZE System. Additionally, U.S. Patent No. 11224483 describes a unique form of 2D-3D image co-registration via machine learning in which the learning phase is performed solely upon the 3D scan of the same patient of whom 2D images are later acquired.
Currently in clinical validation, the VUZE System is used in common spinal stabilization surgeries performed in outpatient or ambulatory settings. The system uses no sensors, cameras or reference arrays, nor does it require any calibrations or lines of sight. It can be used with standard surgical tools and implants with no tool add-ons or modifications.
More than 3 million surgeries for correcting spinal instability and/or deformation, collectively known as spinal stabilizations, are performed annually worldwide, with a third of those in the U.S.1 These procedures include vertebral fixation with pedicle screws, vertebral fixation coupled with fusion, and vertebral augmentation with synthetic or biological cement. Approximately 80 percent of stabilizations treat short spinal segments.1 Short-segment surgeries are most often performed manually and are typically assisted only by standard 2D X-ray.
VUZE Medical is a privately-held medical technology company that aims to provide highly accurate and cost-effective surgical guidance for common spinal interventions currently aided only by standard 2D X-ray alone. The company’s VUZE System is a software-only solution that instantly merges intra-operative X-ray with pre-operative CT.
Reference
1 Orthopedic Network News: 2020 Spinal Surgery Update.
U.S., European, and Chinese regulators awarded the company patents for its VUZE System, a software-only solution that overlays a graphical representation of tools seen in intra-operative 2D images onto axial and sagittal views generated from the patient’s standard pre-operative 3D scan. The U.S. Food and Drug Administration granted the System 510(k) clearance in January.
“These new patents further establish our intellectual property as one of the unique strengths of the VUZE solution,” said David Tolkowsky, VUZE Medical CEO. “We believe that our continued commitment to investing in IP will translate in the near future into further patents granted worldwide.”
Chinese Patent No. 109195527B and European Patent No. 3429475 follow previously issued U.S. Patent No. 10716631 in describing the core workflow of the VUZE System. Additionally, U.S. Patent No. 11224483 describes a unique form of 2D-3D image co-registration via machine learning in which the learning phase is performed solely upon the 3D scan of the same patient of whom 2D images are later acquired.
Currently in clinical validation, the VUZE System is used in common spinal stabilization surgeries performed in outpatient or ambulatory settings. The system uses no sensors, cameras or reference arrays, nor does it require any calibrations or lines of sight. It can be used with standard surgical tools and implants with no tool add-ons or modifications.
More than 3 million surgeries for correcting spinal instability and/or deformation, collectively known as spinal stabilizations, are performed annually worldwide, with a third of those in the U.S.1 These procedures include vertebral fixation with pedicle screws, vertebral fixation coupled with fusion, and vertebral augmentation with synthetic or biological cement. Approximately 80 percent of stabilizations treat short spinal segments.1 Short-segment surgeries are most often performed manually and are typically assisted only by standard 2D X-ray.
VUZE Medical is a privately-held medical technology company that aims to provide highly accurate and cost-effective surgical guidance for common spinal interventions currently aided only by standard 2D X-ray alone. The company’s VUZE System is a software-only solution that instantly merges intra-operative X-ray with pre-operative CT.
Reference
1 Orthopedic Network News: 2020 Spinal Surgery Update.